The latest medical news on Chronic Myeloid Leukaemia

The research magnet gathers the latest research from around the web, based on your specialty area. Below you will find a sample of some of the most recent articles from reputable medical journals about chronic myeloid leukaemia gathered by our medical AI research bot.

The selection below is filtered by medical specialty. Registered users get access to the Plexa Intelligent Filtering System that personalises your dashboard to display only content that is relevant to you.

Want more personalised results?

Request Access
Recovering from CML

This should probably be a really joyful post. This weekend has marked 3 years since I came off chemo. But of course it’s all intertwined wit...

Recovering from CML

Well, it's another month no doubt made up by social media companies that I can jump on the bandwagon about.  And shout about.  Angrily.  Wha...

Recovering from CML

 Again. So much to write. Getting the words out is hard. Moving through the stages of grief. Anger. I’m so fucking furious at the moment. Wi...

Recovering from CML

It’s been a while. Years. So many things to say. So much I can’t. Because it’s not my story to tell. It’s ours. We were a we. And now I’m an...

Dr Brian Koffman on CML

Medically reviewed and interview by Dr. Brian Koffman.The Bottom Line:This new research identifies some of the genetic changes that drive the evolu...

Dr Brian Koffman on CML

Bottom Line:This meta-analysis or combination of 61 trials demonstrated that atrial fibrillation, hypertension, and diarrhea were more common with ...

Dr Brian Koffman on CML

I have good reasons to believe it is time to re-treat my CLL.Before deciding on the best therapy choice to treat my CLL/SLL (chronic lymphocytic le...

Dr Brian Koffman on CML

At the American Society of Hematology (ASH) 2021 Annual Conference and Exhibition, I interviewed Dr. Jeff Sharman, a hematologist/oncologist at Wil...

Dr Brian Koffman on CML

 In an oral presentation during ASH 2020, Dr. Anthony Mato discussed LOXO-305, a new generation BTKi (Bruton Tyrosine Kinase Inhibitor) that blocks...

Dr Brian Koffman on CML

  The Bruton’s tyrosine kinase (BTK) inhibitor ibrutinib and BCL2 inhibitor venetoclax have been very successful as individual therapies for treati...

Dr Brian Koffman on CML

Richter’s transformation (a.k.a. Richter’s syndrome) is a rare complication of chronic lymphocytic leukemia (CLL) where the cancer cells transform ...

Dr Brian Koffman on CML

At the virtual ASH 2020 Annual Conference and Exposition, Dr. John Pagel of Swedish Hospital and one of CLL Society’s directors interviewed Dr. Arn...